Alar Pharmaceuticals Inc. (TPEX:6785)

Alar Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,552	9,452	11,942	6,555	2,608	2,793
Market Cap Growth	-57.36%	-20.85%	82.17%	151.37%	-6.63%	-
Enterprise Value	7,143	7,028	11,326	6,046	2,053	2,171
Last Close Price	143.00	141.50	208.35	114.37	45.50	48.73
PE Ratio	2369.73	520.21	31.21	-	-	-
PS Ratio	1642.15	1624.93	25.45	8193.75	-	4655.00
PB Ratio	3.84	3.79	13.31	12.74	4.88	4.67
P/TBV Ratio	3.84	3.79	13.31	12.74	4.88	4.67
P/FCF Ratio	-	-	30.06	-	-	-
P/OCF Ratio	-	-	29.59	-	-	-
EV/Sales Ratio	-	1208.22	24.14	7557.22	-	3617.60
EV/EBITDA Ratio	-	-	29.22	-	-	-
EV/EBIT Ratio	-	-	29.38	-	-	-
EV/FCF Ratio	-74.48	-	28.51	-	-	-
Debt / Equity Ratio	0.00	0	0.00	0.01	0.00	0.00
Debt / EBITDA Ratio	-	-	0.00	-	-	-
Debt / FCF Ratio	-	-	0.00	-	-	-
Asset Turnover	0.00	0.00	0.63	0.00	-	0.00
Quick Ratio	44.54	44.14	11.98	90.70	116.51	135.92
Current Ratio	44.81	44.33	12.08	92.66	118.67	143.31
Return on Equity (ROE)	0.16%	1.07%	54.21%	-3.79%	-11.34%	-36.17%
Return on Assets (ROA)	-2.14%	-2.41%	32.22%	-5.47%	-10.20%	-26.68%
Return on Capital (ROIC)	-2.20%	-2.50%	34.04%	-5.53%	-10.27%	-26.90%
Return on Capital Employed (ROCE)	-	-	42.90%	-	-	-
Earnings Yield	0.04%	0.19%	3.20%	-0.30%	-2.46%	-5.11%
FCF Yield	-1.00%	-0.74%	3.33%	-0.52%	-2.49%	-5.10%
Dividend Yield	0.17%	0.18%	0.72%	-	-	-
Payout Ratio	2485.74%	551.46%	-	-	-	-
Buyback Yield / Dilution	-15.57%	-16.08%	-0.09%	-	-14.21%	-42.59%
Total Shareholder Return	-15.40%	-15.90%	0.63%	-	-14.21%	-42.59%

Updated Mar 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.